Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report

BACKGROUND: Maintenance therapy using poly(adenosine diphosphate-ribose)polymerase inhibitors may have adverse events, including hematological toxicity, and may limit therapeutic potential in patients with cancer. Niraparib-induced anemia negatively impacts one’s quality of life. Its amelioration by...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Hiroshi, Yamada, Yuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694605/
https://www.ncbi.nlm.nih.gov/pubmed/36424618
http://dx.doi.org/10.1186/s13256-022-03666-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694605/
https://www.ncbi.nlm.nih.gov/pubmed/36424618
http://dx.doi.org/10.1186/s13256-022-03666-3

Ejemplares similares